Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Psoriasis: HELP
Lars Röse
Based on 2 articles published since 2008
||||
Expertise Level

  What is this?

Expertscape's algorithms degrade at low publication numbers. Thus, with only 2 published articles on Psoriasis from 2008 through 2019, it is not possible for Expertscape to reliably rate Lars Röse's expertise on this topic.

Uncounted papers?
Work Locations
Details
Most likely:    Bayer AG      
2012
  • Immunotherapy & Antibody-Drug Conjugates, Bayer Pharma AG, Berlin, Germany. · Pubmed 22151387
2011
  • Corporate Development-Innovation, Bayer AG, Leverkusen, Germany. · Pubmed 21158938
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Lars Röse in 2008-2019 about Psoriasis:

  • Extended DNFB-induced contact hypersensitivity models display characteristics of chronic inflammatory dermatoses. 2012
  • Inhibition of the IL-2-inducible tyrosine kinase (Itk) activity: a new concept for the therapy of inflammatory skin diseases. 2011
Show List of Full Article Records
Google Searches

Learn more about Lars Röse using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Bayer AG
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Bayer AG
2012
  • Immunotherapy & Antibody-Drug Conjugates, Bayer Pharma AG, Berlin, Germany. · Pubmed 22151387
2011
  • Corporate Development-Innovation, Bayer AG, Leverkusen, Germany. · Pubmed 21158938
Yearly article counts 000000011000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.